Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the effects of a single sc administration of TEZAMPANEL at one of three different
dosage levels compared to placebo, employing traditional measures of efficacy and safety in
the treatment of a single episode of acute migraine.